CGC
Price
$2.90
Change
-$0.15 (-4.92%)
Updated
Dec 18, 04:09 PM (EDT)
50 days until earnings call
CYTH
Price
$0.66
Change
-$0.00 (-0.00%)
Updated
Dec 18, 02:24 PM (EDT)
89 days until earnings call
Ad is loading...

CGC vs CYTH

Header iconCGC vs CYTH Comparison
Open Charts CGC vs CYTHBanner chart's image
Canopy Growth
Price$2.90
Change-$0.15 (-4.92%)
Volume$2.4K
CapitalizationN/A
Cyclo Therapeutics
Price$0.66
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
CGC vs CYTH Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. CYTH commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and CYTH is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (CGC: $3.05 vs. CYTH: $0.66)
Brand notoriety: CGC: Notable vs. CYTH: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 63% vs. CYTH: 806%
Market capitalization -- CGC: $784.64M vs. CYTH: $39.05M
CGC [@Pharmaceuticals: Other] is valued at $784.64M. CYTH’s [@Pharmaceuticals: Other] market capitalization is $39.05M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCYTH’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CYTH’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGC and CYTH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while CYTH’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 5 bearish.
  • CYTH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CGC and CYTH are a bad buy in the short-term.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а -12.36% price change this week, while CYTH (@Pharmaceuticals: Other) price change was +6.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.62%. For the same industry, the average monthly price growth was +2.81%, and the average quarterly price growth was -7.89%.

Reported Earning Dates

CGC is expected to report earnings on Feb 06, 2025.

CYTH is expected to report earnings on Mar 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.62% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($785M) has a higher market cap than CYTH($39.1M). CGC YTD gains are higher at: -40.313 vs. CYTH (-58.491). CYTH has higher annual earnings (EBITDA): -20.03M vs. CGC (-1.02B). CGC has more cash in the bank: 186M vs. CYTH (9.25M). CYTH has less debt than CGC: CYTH (1.03M) vs CGC (693M). CGC has higher revenues than CYTH: CGC (362M) vs CYTH (1.08M).
CGCCYTHCGC / CYTH
Capitalization785M39.1M2,008%
EBITDA-1.02B-20.03M5,104%
Gain YTD-40.313-58.49169%
P/E RatioN/AN/A-
Revenue362M1.08M33,643%
Total Cash186M9.25M2,011%
Total Debt693M1.03M67,086%
FUNDAMENTALS RATINGS
CGC vs CYTH: Fundamental Ratings
CGC
CYTH
OUTLOOK RATING
1..100
6377
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9289
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5010

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CGC's Valuation (80) in the Agricultural Commodities Or Milling industry is in the same range as CYTH (95) in the null industry. This means that CGC’s stock grew similarly to CYTH’s over the last 12 months.

CGC's Profit vs Risk Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as CYTH (100) in the null industry. This means that CGC’s stock grew similarly to CYTH’s over the last 12 months.

CGC's SMR Rating (98) in the Agricultural Commodities Or Milling industry is in the same range as CYTH (100) in the null industry. This means that CGC’s stock grew similarly to CYTH’s over the last 12 months.

CYTH's Price Growth Rating (89) in the null industry is in the same range as CGC (92) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

CYTH's P/E Growth Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCYTH
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JKS26.56-0.11
-0.41%
Jinkosolar Holdings CO
FELE103.99-1.10
-1.05%
Franklin Electric Co
MSCI611.50-6.88
-1.11%
MSCI
FRST12.24-0.22
-1.77%
Primis Financial Corp
OMIC19.71-0.36
-1.79%
Singular Genomics Systems Inc.

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with ACB. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
+0.33%
ACB - CGC
84%
Closely correlated
+4.20%
TLRY - CGC
78%
Closely correlated
+3.33%
SNDL - CGC
77%
Closely correlated
+4.17%
CRON - CGC
69%
Closely correlated
+1.04%
OGI - CGC
53%
Loosely correlated
+5.23%
More

CYTH and

Correlation & Price change

A.I.dvisor tells us that CYTH and ACB have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYTH and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTH
1D Price
Change %
CYTH100%
+13.80%
ACB - CYTH
24%
Poorly correlated
+4.20%
RDHL - CYTH
24%
Poorly correlated
-3.37%
TEVA - CYTH
22%
Poorly correlated
+26.47%
CGC - CYTH
22%
Poorly correlated
+0.33%
PTPI - CYTH
21%
Poorly correlated
+87.27%
More